CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
HIL Applied Medical is developing a compact and efficient proton therapy system for cancer treatment. By utilizing advanced particle acceleration technology, the project aims to make proton therapy more accessible and affordable, addressing the significant demand for cancer treatment facilities worldwide.
HIL Applied Medical is developing ultra-compact, high-performance system for cancer Proton Therapy (PT). HIL’s advanced particle accelerator and beamline technologies aim to make PT widely accessible, thus creating a market potential in excess of $2B/year for HIL. HIL’s technology originated in breakthroughs achieved at the Hebrew University in Jeruslaem, Israel, and is not expected to require clinical trials.
Currently there are only 61 operating PT facilities in the world, addressing only 3-5…
HIL APPLIED MEDICAL LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
